Vor Biopharma (VOR) Payables (2020 - 2026)
Vor Biopharma (VOR) posted quarterly Payables of $1.0 million for Q1 2026, down 72.05% year-over-year from $3.7 million in Q1 2025, and down 79.66% quarter-over-quarter from $5.1 million in Q4 2025.
Vor Biopharma (VOR) Payables (2020 - 2026) Analysis & Trends
Vor Biopharma (VOR) has reported Payables for 7 consecutive years, with $1.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Payables fell 72.05% year-over-year to $1.0 million; the TTM figure through Mar 2026 stood at $1.0 million (down 72.05% YoY), while the FY2025 annual figure was $5.1 million, up 240.66% from the prior year.
- Payables eased to $1.0 million in Q1 2026 per VOR's latest filing, from $5.1 million in the prior quarter.
- Across five years, Payables topped out at $5.1 million in Q4 2025 and bottomed at $669000.0 in Q2 2025.
- Historically, Payables has averaged $1.8 million across 5 years, with a median of $1.3 million in 2024.
- Annual changes were most pronounced in 2025 — Payables surged 240.66% — and 2026, when it plunged 72.05%.
- Vor Biopharma's Payables stood at $1.8 million in 2022, then sank by 54.01% to $815000.0 in 2023, then jumped by 84.66% to $1.5 million in 2024, then soared by 240.66% to $5.1 million in 2025, then slumped by 79.66% to $1.0 million in 2026.
- Business Quant data shows VOR's Payables at $1.0 million in Q1 2026, $5.1 million in Q4 2025, and $885000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Vor Biopharma | 1.36 Bn | 1.36 Bn | - | 4.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.00 Mn |
| Mar 31, 2026 | 1.04 Mn |
| Dec 31, 2025 | 5.13 Mn |
| Sep 30, 2025 | 885,000.00 |
| Jun 30, 2025 | 669,000.00 |
| Mar 31, 2025 | 3.73 Mn |
| Dec 31, 2024 | 1.51 Mn |
| Sep 30, 2024 | 1.32 Mn |
| Jun 30, 2024 | 2.01 Mn |
| Mar 31, 2024 | 2.33 Mn |
| Dec 31, 2023 | 815,000.00 |
| Sep 30, 2023 | 1.31 Mn |
| Jun 30, 2023 | 1.65 Mn |
| Mar 31, 2023 | 3.22 Mn |
| Dec 31, 2022 | 1.77 Mn |
| Sep 30, 2022 | 824,000.00 |
| Jun 30, 2022 | 1.27 Mn |
| Mar 31, 2022 | 1.26 Mn |
| Dec 31, 2021 | 1.55 Mn |
| Sep 30, 2021 | 1.96 Mn |